BridgeBio(US:BBIO) Benzinga·2026-02-22 15:00Group 1 - Genuine Parts Company (NYSE:GPC) fell 19.51% after reporting worse-than-expected fourth-quarter financial results and issuing FY26 EPS guidance below estimates, leading to multiple analysts lowering their price forecasts [1] - Flutter Entertainment plc (NYSE:FLUT) decreased 11.86% ahead of its fourth quarter and full year 2025 financial results scheduled for release on February 26 [2] - Okta, Inc. (NASDAQ:OKTA) fell 12.86% as multiple firms lowered their respective price targets on the stock [2] Group 2 - BorgWarner Inc. (NYSE:BWA) slumped 10.59% following a downgrade from UBS analyst Joseph Spak from Neutral to Sell, with the price target raised from $49 to $55 [3] - Expedia Group, Inc. (NASDAQ:EXPE) fell 4.32%, with Wedbush analyst Scott Devitt reiterating a Neutral rating and maintaining a $260 price forecast [3] - BridgeBio Pharma, Inc. (NASDAQ:BBIO) slumped 11.43% this week [3]